This clause on Epainassist.com has been look back by a medical professional , as well as check for facts , to guarantee the lector the best potential accuracy .
We observe a stern editorial insurance policy and we have a zero - tolerance policy regarding any story of piracy . Our article are resourced from reputable on-line pages . This clause may contains scientific cite . The telephone number in the digression ( 1 , 2 , 3 ) are clickable links to match - review scientific papers .
The feedback link “ Was this Article Helpful ” on this page can be used to report content that is not precise , up - to - particular date or confutable in any manner .
This article does not bring home the bacon aesculapian advice .
Cirrhosis of Liver is a disease in which sizeable tissues in theliverget supercede by fibrous scar tissue . Cirrhosis eventually results in liver failure , which forestall the liver from functioning adequately . It is estimated that Cirrhosis of Liver is the twelfth leading causal agency of death due to a aesculapian status . In this article , we will scan in detail about the various causes , symptom , and treatment of treatments , and if there is any agency that we can prevent Cirrhosis of Liver .
How Is Cirrhosis Of Liver Defined?
Causes Of Cirrhosis Of Liver
Symptoms of Cirrhosis Of Liver
Non-Specific Symptoms of Liver Cirrhosis-
Specific Symptoms of Liver Cirrhosis-
Diagnosis Of Cirrhosis Of Liver
Specific Findings During Clinical Examination-
Lab Studies To Diagnose Cirrhosis of Liver-
Radiological Studies To Diagnose Cirrhosis of Liver:
Endoscopy-
Liver Biopsy
Treatment For Cirrhosis Of Liver
Complications Of Cirrhosis Of Liver
References :
1 . ripe liver disease : What every hepatitis C virus negotiant should know .
Sherman KE
Top Antivir Med . 2011 Aug - Sep;19(3):121 - 5 .
2 . Liver fibrosis .
Wallace K1 , Burt AD , Wright MC .
Biochem J. 2008 Apr 1;411(1):1 - 18 .
3 . Diagnosis and epidemiology of cirrhosis .
Lefton HB1 , Rosa A , Cohen M.
Med Clin North Am . 2009 Jul;93(4):787 - 99 ,
4 . Liver organ transplant and autoimmune liver disease .
Liberal R1 , Zen Y , Mieli - Vergani G , Vergani D.
Liver Transpl . 2013 Oct;19(10):1065 - 77 .
5 . Non - alcoholic fat person liver disease : factors affiliate with its presence and onset .
Miyake T1 , Kumagi T , Furukawa S , Tokumoto Y , Hirooka M , Abe M , Hiasa Y , Matsuura B , Onji M.
J Gastroenterol Hepatol . 2013 Dec;28 Suppl 4:71 - 8 .
6 . Long - terminal figure presidency of rifaximin improve the forecast of patient with decompensated alcoholic cirrhosis .
Vlachogiannakos J1 , Viazis N , Vasianopoulou P , Vafiadis I , Karamanolis DG , Ladas SD .
J Gastroenterol Hepatol . 2013 Mar;28(3):450 - 5 . doi : 10.1111 / jgh.12070 .
7 . Fifty - three years ’ experience with randomize clinical trials of emergency portacaval shunt for bleeding esophageal varices in Cirrhosis : 1958 - 2011 .
Orloff MJ .
J. AMA Surg . 2014 Feb;149(2):155 - 69 .
8 . Management of end - stage liver disease .
Liou IW .
Med Clin North Am . 2014 Jan;98(1):119 - 52 .
